Answers are grounded in this paper and cite their sources.
Ever since the discovery of P-gp in 1975, ATP-binding cassette transporters have captivated basic researchers, microbiologists, and clinicians alike. Numerous processes rely upon these fascinating molecular machines. They regulate homeostatic, developmental, and pathophysiological processes—acting as directional or bidirectional membrane transporters, channels or receptors. Overexpression of ABCs is linked to drug resistance of pathogens and perhaps certain cancers. Inborn errors in genes encoding ABCs cause prominent and prevalent genetic diseases. ABC proteins are also major players in physiological detoxification across barrier tissues. It is thus unsurprising that they are present in all forms of life from bacteria to man. Given this ubiquity, and importance in so many processes, it is worth understanding ABC structures and functions. Yet, many unanswered questions remain. In some cases, we still do not know the natural ligands of these proteins, for others we lack a complete understanding of the mechanics of their transport cycles. Answering these questions is not as easy as ABC. The goal of unraveling these mysteries, and the associated interactions and collaborations, unites an international ABC transporter research community. For the past two decades, the crystallization point for this community has been the Federation of European Biochemical Societies (FEBS) meetings, culminating in the ABC2020 meeting in Innsbruck, Austria. It is from this meeting series that this special issue entitled ‘Diversity of Structure and Function of ABC Transporters’, and its predecessor in 2006 (https://febs.onlinelibrary.wiley.com/toc/18733468/2006/580/4), originates. Back in 2006, there was palpable excitement about the growing list of structures and organisms in which ABC proteins were found, and perhaps a vision of unifying, singular themes in their structure and function. However, if there has been any lesson of the last 15 years, it is that transporter structural mechanisms and physiological functions are as diverse as the processes in which these proteins are implicated. Provided with such a flexible and powerful tool to make cellular membranes selective, it is perhaps not surprising that evolution has found many uses for ABC proteins. This diversity of biological contexts in which ABCs operate, and the broad roles they play in homeostasis, signaling, protection, and disease are the overarching themes of this special issue [[1-4]]. Looking back at the previous ABC Special Issue published by FEBS Letters, the current wealth of ABC transporter structures seems overwhelming. This has been powered by a revolution in structural biology, namely the successful application of cryo-EM to membrane proteins. Cryo-EM offers advantages over classical X-ray approaches, which remain tedious and cumbersome, and, as the ABC field in particular remembers, sometimes yielded structures with limited biological relevance. While cryo-EM produced structures at an astonishing pace, there was a cost, since structures could precede biochemical validation of deduced mechanisms. Several excellent papers in this special issue are dedicated to this controversy, arguing against the idea that the cryo-EM snapshots can be straightforwardly interpreted and used to easily resolve many of the existing controversies within the ABC transporter field [[5, 6]]. Importantly, cryo-EM structures captured along the entire frame of the catalytic cycle confirm the long suspected conformational flexibility as a fundamental feature of ABC proteins [[7]]. This highlights why ABC transporter structural biology has to be accompanied by complementary methods, may they be spectroscopy-based, mechanistic, or cell-based. Additionally, advances in single molecule techniques and theoretical approaches show great potential to help investigate these aspects of ABC transporter mechanisms [[8-12]]. A major conclusion is that structural information should always be interpreted taking into consideration all available biochemical and genetic studies, as well as the technical limitations of in vitro membrane-mimicking environments, as opposed to the native membrane of a living cell [[13-17]]. As this special issue highlights, ABC transporters handle a wide range of structurally dissimilar endo- and xenobiotics in the human body, especially in tissue barriers and metabolizing or secretory organs [[18-21]]. If integration of molecular details into a physiological context is indeed possible, our grasp on the structure and function of ABCs should lead to clinically relevant insights. Evolving biochemical and structural models might help develop therapies to better address diseases related to the malfunctioning of ABCs such as CFTR or ABCC6, resulting in cystic fibrosis and PXE (Pseudoxanthoma elasticum), respectively [[22-25]]. A major landmark since the last special issue has been the development of clinically used CFTR modulators, giving hope to discovery and development of additional therapeutics targeting ABCs [[26]]. In addition, synergy of basic scientists, lay advocates, clinicians, and translational scientists has resulted in important advances leading to clinical trials for the cure of PXE. However, translation of biochemical findings to clinically relevant concepts is not always straightforward. Structural alterations may not only result in defects of transporter or channel activity, but also result in improper folding, derailed trafficking, and degradation [[27]]. The clinical relevance of these alterations in drug metabolism, cancer multidrug resistance, and impaired physiology is also discussed [[28]]. A further emerging theme in this special issue is the interplay between ABC transporters and their environment. As ancient proteins, transporters are found at various developmental stages and play diverse roles from metabolite flux to protection. Transporter systems are adapted to the environment through diverse regulatory mechanisms—often linking multiple transporters into coordinately regulated networks. Examples of these networks are revealed in placental development where environmental signals such as hypoxia can alter levels of multiple transporters simultaneously [[29]]. Studies within this area also point to the potential fragility of the transporter system to perturbations that are outside of the anticipated scope of the environment. One example includes the perturbation of xenobiotic transporting ABCs, such as ABCB1, by ubiquitous environmental pollutants. These transporter interfering chemicals could represent a new class of environmental toxicants that exert their effects by interfering with transporter networks [[30, 31]]. Finally, some papers within this special issue revisit the question of transporter classification. Even though the initial classification of ABC proteins into eight subfamilies (from A to H) has fulfilled its purpose for a while, one question posed in this issue is whether an alternative nomenclature is needed, taking into account functional and structural characteristics distinguishing importers, exporters, channels, or non-transport-related functions. Interestingly, this task turns out to be challenging, especially given the context of emerging new functional information, often in conflict with ‘established’ knowledge [[32]]. Here, genuine attempts to reclassify ABC transporters based on their TMD folds [[33]] or on evolutionary relationships obtained from the combination of natural and experimentally produced sequence variations are proposed [[34, 35]]. Hopefully, this will stimulate debate, leading to the refinement of new proposals. In this regard, we anticipate that important benchmarks for the validity of any reclassification will be the level of new insight provided by the emergent properties of ABC subfamilies and how this information will help explain what remains not understood. The biannual FEBS ABC meetings have been the ‘home base’ for the global ABC community. Many key discoveries in the field emerged from collaborations initiated at the ABC meetings. Therefore, in this special issue, personal accounts of the groundbreaking ideas, the ensuing debates, and controversies are provided by some of the mavens of the field [[36]]. The meetings have also fostered the training of generations of new scientists who are currently propelling the field. We have seen numerous examples of undergraduate ABC meeting participants walking along their career paths to become renowned investigators, with seminal contributions. Many discoveries presented at the ABC meetings mark the current frontiers, and the recent ones justify a dedicated special issue about the key advances but also highlighting open questions and controversies. As only the second special issue in the 23-year history of the ABC meetings, it comes at an exciting time in which new technologies allow us to revisit the validity of old models, spark new questions and a renaissance of neglected ones, and examine how the study of ABC transporters has impacted on diverse research fields. As the participants of the 2020 FEBS Special Meeting on ABC Transporters may vividly recall, there were many, often fiery debates about whether more or less structures should be presented at these meetings, whether the field will diversify into smaller ‘specialty’ subfields, or whether animal and patient work had unrightfully taken a back seat in recent years. No matter where one stood in these debates, new technical developments will redefine such views and positions. Indeed, some readers may remember a time when almost all work on ABC transporters was animal- or cell-based, while structural biology and molecular biology were beyond reach. Now, it seems possible to re-integrate the molecular and structural work with in cellulo and in vivo experiments and, importantly, establish ecological and evolutionary significance. This special issue is by no means a compendium of all ABC transporter knowledge; rather, it reflects a snapshot of the ideas that currently intrigue ABC scientists. Encouragingly, our SI covers many different aspects, some conceptional (nomenclature) or historical (where are we coming from?), some exploratory (where will we go?), some others pertaining to molecules (ABC structures) or whole organisms (ABCs in animals), and some having clinical relevance (genetic diseases), but all showing that, even after decades in this field, there is no shortage of interesting questions and passionate researchers pursuing them. Amro Hamdoun—Professor, University of California, San Diego. Amro Hamdoun’s research concerns the roles of ABC transporters in early embryonic development and in protection from environmental toxicants. The laboratory has used the sea urchin embryo to describe the spatial and temporal patterns of ABC transporter expression during development and uncovered ontogenetic switches in transport activity that appear to be conserved parts of developmental programs. In the field of toxicology, his laboratory has focused on the discovery of ubiquitous environmental toxicants that interact with ABCB1 (aka P-glycoprotein) and description of the mechanisms by which these potentially interfere with its function. These studies were the first to provide detailed views of the interaction between a xenobiotic transporter (ABCB1) and a ubiquitous environmental compound. Ute A. Hellmich—Friedrich-Schiller-University, Institute of Organic Chemistry and Macromolecular Chemistry, Cluster of Excellence ‘Balance of the Microverse’, Jena, Germany. Ute Hellmich’s group is interested in membrane protein–lipid interactions and protein dynamics, in particular how nucleotide binding and hydrolysis trigger long-range conformational changes and substrate translocation in bacterial ABC transporters. The laboratory uses an integrated structural biology approach to observe how ABC transporters move as they interact with different ligands. After a PhD at Frankfurt University, Germany, and a postdoc at Harvard University, she was an assistant professor for membrane biochemistry at Mainz University and an adjunct member at the Centre for Biomolecular Magnetic Resonance (BMRZ) at Frankfurt University. In 2021, she joined the Institute of Organic Chemistry and Macromolecular Chemistry and the Microverse Cluster at the Friedrich-Schiller-University in Jena, Germany, as a full professor to study structural and dynamic aspects of microbial communication. Gergely Szakacs—Medical University of Vienna,Austria. Gergely Szakacs’s work focuses on membrane transport biology and the multidrug resistance phenotype of cancer cells. Following his graduate training as a physician scientist, he completed his postdoctoral studies at the National Cancer Institute (USA), where he identified compounds selectively targeting multidrugresistant cancer. In 2007, he joined the Hungarian Academy of Sciences as a group leader in the Institute of Enzymology. In 2012, he obtained an ERC Starting Grant to develop MDR-selective compounds targeting the Achilles heel of multidrug-resistant cancer. In 2017, he was appointed as full professor at the Institute for Cancer Research, Medical University of Vienna. Karl Kuchler—Medical University of Vienna, Max Perutz Labs Vienna, Austria. Karl Kuchler has been studying ABC transporter in yeast and mammalian cells for many years. He has initially discovered most yeast ABC transporters and studied their regulation under physiological and stress conditions. While the main interest was originally focusing on the mechanisms of pleiotropic drug resistance in yeast and fungal pathogens, the group is now centering the attention to those human ABC transporters showing the highest evolutionary conservation with fungal drug resistance transporters. The group is trying to integrate biochemical, biophysical, structural, cell biological, and genetic approaches to decipher the mechanisms how human ABC transporters mediate multidrug resistance and how that knowledge could improve therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Hamdoun et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: